A startup that wants to make treatments that edit single letters in our DNA just raised $87 million
Business Insider -

Beam Therapeutics, a new startup co-founded by gene-editing pioneers, just raised $87 million to get its technology that changes single letters in DNA into humans. 

The cutting-edge technology, known as base editing, acts as a molecular pencil, co-founder David Liu told Business Insider. In contrast, CRISPR, another new gene-editing technology acts more like scissors, cutting out larger chunks of DNA on a particular gene. 

The technology is still in early days, though the company said it has...


Related Articles